In order to investigate the specific mechanism mediating the loss of synaptic plasticity during EAE, we tested the effect of an inhibitor of NADPH oxidase, apocynin, and found that it was able to restore the LTP deficit observed during the remission phase of experimental multiple sclerosis. Here, FMO5 is linked to multiple sclerosis.